Android app on Google Play

After-Hours Movers 07/31: (SIMG) (DEPO) (MRGE) Higher; (CECO) (PPO) (DRIV) Lower

July 31, 2012 6:23 PM EDT Send to a Friend
Silicon Image, Inc. (Nasdaq: SIMG) 23.7% HIGHER; reported Q2 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $63.8 million versus the consensus estimate of $60.4 million. Silicon Image, Inc. sees Q3 2012 revenue of $73-$75 million, versus the consensus of $70.25 million.

Career Education Corp (Nasdaq: CECO) 17.6% LOWER; reported Q2 EPS of ($0.18), $0.17 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $369 million versus the consensus estimate of $382.97 million. Student population down 24% to 77,600. New enrollments down 40% to 15,000.

Polypore International (NYSE: PPO) 14.8% LOWER; reported Q2 EPS of $0.51, $0.03 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $185.8 million versus the consensus estimate of $185.83 million.

Digital River, Inc. (Nasdaq: DRIV) 14.5% LOWER; reported Q2 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $90.8 million versus the consensus estimate of $93.37 million. Sees Q3 2012 EPS of $0.12-$0.18, versus the consensus of $0.26 and revenue of $88-$91 million, versus the consensus of $97.1 million. Digital River also sees FY2012 EPS of $0.96-$1.08, versus the consensus of $1.22 and revenue of $378-$390 million, versus the consensus of $405.9 million. Authorized a new share repurchase program of up to $100 million of its outstanding common shares.

True Religion Apparel, Inc. (Nasdaq: TRLG) 13.1% LOWER; reported Q2 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $104.9 million versus the consensus estimate of $107.31 million. Sees FY2012 EPS of $1.80-$1.86, versus the consensus of $1.97. True Religion Apparel, Inc. sees FY2012 revenue of $450-$455 million, versus the consensus of $467.84 million.

TTM Technologies, Inc. (Nasdaq: TTMI) 10.2% LOWER; reported Q2 EPS of $0.17, $0.06 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $327.4 million versus the consensus estimate of $330.42 million. Sees Q3 2012 EPS of $0.16-$0.24, versus the consensus of $0.33. TTM Technologies, Inc. sees Q3 2012 revenue of $340-$360 million, versus the consensus of $362.32 million.

McGrath Rentcorp (Nasdaq: MGRC) 9.8% LOWER; reported Q2 EPS of $0.42, $0.06 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $86.87 million. Sees FY2012 EPS of $1.70-$1.85, versus prior guidance of $2.02-$2.12 and the consensus of $2.05.

Depomed, Inc. (Nasdaq: DEPO) 8.5% HIGHER; announced that it has submitted a New Drug Application (NDA) for Serada to the United States Food and Drug Administration. Serada is Depomed's proprietary extended release formulation of gabapentin in development for the treatment of menopausal hot flashes.

Merge Healthcare, Inc. (Nasdaq: MRGE) 8.1% HIGHER; reported Q2 adjusted EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $62.9 million versus the consensus estimate of $60.6 million.

The Chefs' Warehouse (Nasdaq: CHEF) 7.7% LOWER; reported Q2 EPS of $0.23, $0.01 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $114.8 million versus the consensus estimate of $118.05 million. Sees FY2012 EPS of $0.80-$0.86, versus the consensus of $0.91 and revenue of $445-$455 million, versus the consensus of $463.11 million.

Papa John's Int'l (Nasdaq: PZZA) 6.6% HIGHER; reported Q2 EPS of $0.61, $0.05 better than the analyst estimate of $0.56. Revenue for the quarter came in at $318.6 million versus the consensus estimate of $311.07 million. Sees FY2012 EPS of $2.45-$2.55, versus prior guidance of $2.40-$2.50 and the consensus of $2.52.

Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) 5.2% LOWER; commenced an underwritten registered public offering of $150 million of its common stock. All of these shares are being sold by Idenix.

Optimer Pharmaceuticals (Nasdaq: OPTR) 4.8% LOWER; reported Q2 EPS of ($0.01), $0.06 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $49.47 million.

Sourcefire, Inc. (Nasdaq: FIRE) 4.4% LOWER; reported Q2 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $50.6 million versus the consensus estimate of $48.86 million.

Black Box Corp (Nasdaq: BBOX) reported Q1 EPS of $0.53, $0.09 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $248 million versus the consensus estimate of $256.2 million. Sees FY2013 EPS of $2.45-$2.85, versus the consensus of $2.88. Black Box Corp sees FY2013 revenue of $990 million-1.03 billion vs. consensus of $1.08 billion.

Allstate Corp. (NYSE: ALL) 3.9% HIGHER; reported Q2 EPS of $0.97, $0.08 better than the analyst estimate of $0.89. Revenue for the quarter came in at $8.28 billion versus the consensus estimate of $6.85 billion.

FalconStor Software, Inc. (Nasdaq: FALC) 3.5% LOWER; reported Q2 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $19.44 million.




You May Also Be Interested In


Related Categories

Special Reports

Related Entities

After-Hours Movers, Stock Buyback

Add Your Comment